The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.

doi:10.1200/JCO.2021.39.15_suppl.e16005

	The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.
	Xu, Jianming ; Zhang, Yun ; Wu, Jun ; Xu, Nong ; Ying, Jieer ; Xiang, Xiaojun ; Zhang, Yanqiao ; Wang, Jianhong ; Zhao, Rusen ; Ye, Feng
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2021-05-20
卷号	39
ISSN号	0732-183X
DOI	10.1200/JCO.2021.39.15_suppl.e16005
资助项目	Alphamab Oncology Ltd
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000708120301280
资助机构	Alphamab Oncology Ltd
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/126582]
专题	中国科学院合肥物质科学研究院
作者单位	1.Chinese PLA Gen Hosp, Dept GI Oncol, Med Ctr 5, Beijing, Peoples R China 2.Alphamab Oncol Ltd, Suzhou, Peoples R China 3.Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China 4.Zibo Municipal Hosp, Zibo, Peoples R China 5.Nantong Tumor Hosp, Nantong, Peoples R China 6.Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Peoples R China 7.Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China 8.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Chinese Acad Sci,Canc Hosp, Inst Canc & Basic Med IBMC, Hangzhou, Zhejiang, Peoples R China 9.Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, Hangzhou, Peoples R China 10.First Peoples Hosp Changzhou, Changzhou, Jiangsu, Peoples R China
推荐引用方式 GB/T 7714	Xu, Jianming,Zhang, Yun,Wu, Jun,et al. The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39.
APA	Xu, Jianming.,Zhang, Yun.,Wu, Jun.,Xu, Nong.,Ying, Jieer.,...&Xu, Ting.(2021).The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression..JOURNAL OF CLINICAL ONCOLOGY,39.
MLA	Xu, Jianming,et al."The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.".JOURNAL OF CLINICAL ONCOLOGY 39(2021).